MOH RSI Chart
Last 7 days
2.3%
Last 30 days
-7.1%
Last 90 days
-3.3%
Trailing 12 Months
18.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 35.9B | 0 | 0 | 0 |
2023 | 32.4B | 32.6B | 33.2B | 34.1B |
2022 | 29.0B | 30.3B | 31.2B | 32.0B |
2021 | 21.4B | 23.6B | 25.6B | 27.8B |
2020 | 17.3B | 17.7B | 18.5B | 19.4B |
2019 | 18.4B | 17.7B | 17.2B | 16.8B |
2018 | 19.6B | 19.5B | 19.2B | 18.9B |
2017 | 18.3B | 19.0B | 19.5B | 19.9B |
2016 | 15.3B | 16.2B | 17.1B | 17.8B |
2015 | 10.8B | 12.0B | 13.1B | 14.2B |
2014 | 7.1B | 7.8B | 8.6B | 9.7B |
2013 | 6.2B | 6.3B | 6.4B | 6.6B |
2012 | 4.8B | 5.1B | 5.5B | 5.9B |
2011 | 4.2B | 4.4B | 4.5B | 4.5B |
2010 | 0 | 3.8B | 3.9B | 4.1B |
2009 | 0 | 0 | 0 | 3.7B |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 01, 2024 | cooperman daniel | acquired | 54,971 | 404 | 136 | - |
Apr 01, 2024 | schapiro richard m | acquired | 54,971 | 404 | 136 | - |
Apr 01, 2024 | orlando steven j | acquired | 54,971 | 404 | 136 | - |
Apr 01, 2024 | romney ronna | acquired | 54,971 | 404 | 136 | - |
Apr 01, 2024 | wolf dale b | acquired | 54,971 | 404 | 136 | - |
Apr 01, 2024 | zoretic richard c | acquired | 54,971 | 404 | 136 | - |
Apr 01, 2024 | brasier barbara l | acquired | 54,971 | 404 | 136 | - |
Apr 01, 2024 | lockhart stephen h | acquired | 54,971 | 404 | 136 | - |
Mar 01, 2024 | bacon debra | acquired | 880,128 | 387 | 2,273 | evp, medicaid |
Mar 01, 2024 | zubretsky joseph m | sold (taxes) | -23,016,900 | 387 | -59,443 | president & ceo |
Which funds bought or sold MOH recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | Manchester Capital Management LLC | unchanged | - | 297 | 2,465 | -% |
May 06, 2024 | Parallel Advisors, LLC | reduced | -48.9 | -69,034 | 95,723 | -% |
May 06, 2024 | NEW YORK LIFE INVESTMENT MANAGEMENT LLC | reduced | -3.97 | 280,024 | 3,327,310 | 0.03% |
May 06, 2024 | MGB Wealth Management, LLC | added | 12.67 | 76,168 | 347,151 | 0.14% |
May 06, 2024 | Advisory Services Network, LLC | added | 61.98 | 309,644 | 677,458 | 0.01% |
May 06, 2024 | DiNuzzo Private Wealth, Inc. | reduced | -10.00 | 84.00 | 3,698 | -% |
May 06, 2024 | LEUTHOLD GROUP, LLC | reduced | -4.28 | 42,543 | 523,808 | 0.06% |
May 06, 2024 | TEXAS PERMANENT SCHOOL FUND CORP | reduced | -0.4 | 576,353 | 4,925,440 | 0.04% |
May 06, 2024 | LMCG INVESTMENTS, LLC | reduced | -30.01 | -195,169 | 760,857 | 0.04% |
May 06, 2024 | TEACHER RETIREMENT SYSTEM OF TEXAS | added | 26.29 | 2,337,000 | 7,698,000 | 0.05% |
Unveiling Molina Healthcare Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Molina Healthcare Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 462.0B | 371.6B | 20.64 | 1.24 | ||||
CI | 98.5B | 206.0B | 25.56 | 0.48 | ||||
HCA | 82.4B | 66.7B | 15.06 | 1.23 | ||||
CVS | 70.0B | 360.9B | 9.55 | 0.19 | ||||
CNC | 40.5B | 155.5B | 14.81 | 0.26 | ||||
DVA | 12.1B | 12.3B | 14.8 | 0.98 | ||||
UHS | 11.7B | 14.3B | 16.37 | 0.82 | ||||
MID-CAP | ||||||||
CHE | 8.8B | 2.3B | 30.96 | 3.83 | ||||
ACHC | 6.3B | 3.0B | -553.66 | 2.09 | ||||
AMN | 2.3B | 3.8B | 10.82 | 0.6 | ||||
AMEH | 2.1B | 1.4B | 34.65 | 1.52 | ||||
SMALL-CAP | ||||||||
ADUS | 1.7B | 1.1B | 26.07 | 1.57 | ||||
BKD | 1.4B | 3.0B | -7.37 | 0.46 | ||||
BEAT | 54.0M | - | -3.69 | - | ||||
AMS | 19.6M | 21.3M | 36.7 | 0.92 |
Molina Healthcare Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | 9.8% | 9,931 | 9,048 | 8,548 | 8,327 | 8,149 | 8,223 | 7,927 | 8,054 | 7,770 | 7,409 | 7,040 | 6,800 | 6,522 | 5,235 | 5,021 | 4,618 | 4,549 | 4,274 | 4,243 | 4,193 | 4,119 |
Costs and Expenses | 8.9% | 9,505 | 8,732 | 8,189 | 7,884 | 7,694 | 8,118 | 7,592 | 7,693 | 7,398 | 7,218 | 6,819 | 6,527 | 6,187 | 5,144 | 4,732 | 4,194 | 4,275 | 4,032 | 3,986 | 3,928 | 3,839 |
S&GA Expenses | 10.2% | 711 | 645 | 608 | 618 | 591 | 629 | 560 | 551 | 571 | 579 | 532 | 484 | 473 | 450 | 368 | 345 | 317 | 343 | 323 | 328 | 302 |
EBITDA Margin | -6.5% | 0.05* | 0.05* | 0.05* | 0.05* | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | 0.05* | - | - | - | - | - | - | - | - | - |
Interest Expenses | 0% | 27.00 | 27.00 | 27.00 | 27.00 | 28.00 | 27.00 | 28.00 | 27.00 | 28.00 | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 | 27.00 | 24.00 | 21.00 | 20.00 | 22.00 | 22.00 | 23.00 |
Income Taxes | 34.2% | 98.00 | 73.00 | 87.00 | 107 | 106 | 22.00 | 77.00 | 86.00 | 86.00 | 33.00 | 48.00 | 58.00 | 77.00 | 17.00 | 77.00 | 119 | 75.00 | 54.00 | 58.00 | 61.00 | 62.00 |
Earnings Before Taxes | 38.1% | 399 | 289 | 332 | 416 | 427 | 78.00 | 307 | 334 | 344 | 136 | 191 | 243 | 305 | 51.00 | 262 | 395 | 253 | 222 | 233 | 257 | 260 |
EBT Margin | -6.8% | 0.04* | 0.04* | 0.04* | 0.04* | 0.04* | 0.03* | 0.04* | 0.03* | 0.03* | 0.03* | 0.03* | 0.04* | - | - | - | - | - | - | - | - | - |
Net Income | 39.4% | 301 | 216 | 245 | 309 | 321 | 56.00 | 230 | 248 | 258 | 103 | 143 | 185 | 228 | 34.00 | 185 | 276 | 178 | 168 | 175 | 196 | 198 |
Net Income Margin | -6.7% | 0.03* | 0.03* | 0.03* | 0.03* | 0.03* | 0.02* | 0.03* | 0.02* | 0.02* | 0.02* | 0.02* | 0.03* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 127.3% | 187 | -685 | 923 | 456 | 884 | -222 | 223 | 341 | 340 | 576 | 434 | 480 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 4.2% | 15,513 | 14,892 | 14,870 | 13,661 | 13,371 | 12,314 | 12,793 | 12,572 | 12,360 | 12,209 | 11,033 | 10,530 | 9,950 | 9,532 | 7,881 | 7,876 | 7,129 | 6,787 | 6,701 | 6,690 | 7,579 |
Current Assets | 1.0% | 12,668 | 12,542 | 12,468 | 11,441 | 11,159 | 10,084 | 10,492 | 10,332 | 10,146 | 10,064 | 9,366 | 8,874 | 8,308 | 7,876 | 6,953 | 7,062 | 6,324 | 5,967 | 5,877 | 5,863 | 6,731 |
Cash Equivalents | -6.9% | 4,513 | 4,848 | 5,565 | 4,910 | 4,554 | 4,048 | 4,242 | 4,312 | 4,804 | 4,438 | 4,357 | 4,608 | 4,431 | 4,223 | 3,196 | 3,303 | 2,365 | 2,508 | 2,679 | 2,253 | 3,224 |
Net PPE | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 327 | 379 | 373 | 376 |
Liabilities | 3.2% | 11,020 | 10,677 | 10,991 | 10,040 | 10,083 | 9,350 | 9,752 | 9,742 | 9,566 | 9,579 | 8,515 | 8,160 | 7,786 | 7,436 | 5,680 | 5,880 | 5,482 | 4,827 | 4,870 | 4,954 | 5,744 |
Current Liabilities | 4.2% | 8,514 | 8,168 | 8,492 | 7,537 | 7,614 | 6,855 | 7,242 | 7,225 | 7,041 | 7,047 | 6,070 | 5,707 | 5,323 | 4,965 | 3,556 | 3,755 | 3,570 | 3,269 | 3,308 | 3,388 | 4,292 |
Long Term Debt | 0% | 2,180 | 2,180 | 2,179 | 2,178 | 2,177 | 2,176 | 2,175 | 2,175 | 2,174 | 2,173 | 2,130 | 2,129 | 2,128 | 2,127 | 1,813 | 1,812 | 1,596 | 1,237 | 1,239 | 1,241 | 1,121 |
LT Debt, Non Current | 0% | 2,180 | 2,180 | 2,179 | 2,178 | 2,177 | 2,176 | 2,175 | 2,175 | 2,174 | 2,173 | 2,130 | 2,129 | 2,128 | 2,127 | 1,813 | 1,812 | 1,596 | 1,237 | 1,239 | 1,241 | 1,121 |
Shareholder's Equity | 6.6% | 4,493 | 4,215 | 3,879 | 3,621 | 3,288 | 2,964 | 3,041 | 2,830 | 2,794 | 2,630 | 2,518 | 2,370 | 2,164 | 2,096 | 2,201 | 1,996 | 1,647 | 1,960 | 1,831 | 1,736 | 1,835 |
Retained Earnings | 7.7% | 4,188 | 3,887 | 3,671 | 3,426 | 3,117 | 2,796 | 2,937 | 2,707 | 2,657 | 2,399 | 2,296 | 2,153 | 1,968 | 1,860 | 1,983 | 1,798 | 1,522 | 1,781 | 1,666 | 1,491 | 1,295 |
Additional Paid-In Capital | -4.9% | 390 | 410 | 373 | 341 | 296 | 328 | 289 | 251 | 218 | 236 | 205 | 191 | 170 | 199 | 181 | 166 | 140 | 175 | 160 | 240 | 543 |
Shares Outstanding | 1.7% | 59.00 | 58.00 | 58.00 | 58.00 | 58.00 | 58.00 | 58.00 | 58.00 | 59.00 | 58.00 | 58.00 | 58.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 17,400 | - | - | - | 16,100 | - | - | - | 14,700 | - | - | - | 10,500 | - | - | - | 8,929 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 131.0% | 214 | -690 | 949 | 487 | 916 | -212 | 254 | 368 | 363 | 597 | 461 | 493 | 568 | 1,299 | -158 | 614 | 143 | 36.00 | 242 | -93.00 | 249 |
Share Based Compensation | 33.3% | 36.00 | 27.00 | 33.00 | 30.00 | 25.00 | 23.00 | 23.00 | 23.00 | 34.00 | 23.00 | 14.00 | 11.00 | 24.00 | 14.00 | 15.00 | 16.00 | 12.00 | 10.00 | 10.00 | 10.00 | 9.00 |
Cashflow From Investing | -1852.0% | -488 | -25.00 | -280 | -137 | -302 | 148 | -347 | -665 | 74.00 | -547 | -698 | -321 | -87.00 | -498 | 60.00 | 141 | -103 | -213 | 313 | -564 | 171 |
Cashflow From Financing | -2166.7% | -62.00 | 3.00 | -6.00 | 10.00 | -65.00 | -183 | 10.00 | -191 | -77.00 | 21.00 | -4.00 | 7.00 | -207 | 156 | -2.00 | 188 | -125 | -49.00 | -148 | -314 | -48.00 |
Buy Backs | - | - | - | - | -200 | - | 200 | - | 200 | - | - | - | 6.00 | 122 | 159 | - | 7.00 | 446 | 47.00 | - | - | - |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue: | ||
Premium revenue | $ 9,504 | $ 7,885 |
Premium tax revenue | 297 | 172 |
Investment income | 108 | 71 |
Other revenue | 22 | 21 |
Total revenue | 9,931 | 8,149 |
Operating expenses: | ||
Medical care costs | 8,414 | 6,871 |
General and administrative expenses | 711 | 591 |
Premium tax expenses | 297 | 172 |
Depreciation and amortization | 45 | 44 |
Other | 38 | 16 |
Total operating expenses | 9,505 | 7,694 |
Operating income | 426 | 455 |
Interest expense | 27 | 28 |
Income before income tax expense | 399 | 427 |
Income tax expense | 98 | 106 |
Net income | $ 301 | $ 321 |
Net income per share: | ||
Net income per share - Basic (in dollars per share) | $ 5.21 | $ 5.58 |
Net income per share - Diluted (in dollars per share) | $ 5.17 | $ 5.52 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 4,513 | $ 4,848 |
Investments | 4,424 | 4,259 |
Receivables | 3,350 | 3,104 |
Prepaid expenses and other current assets | 381 | 331 |
Total current assets | 12,668 | 12,542 |
Property, equipment, and capitalized software, net | 295 | 270 |
Goodwill, and intangible assets, net | 1,927 | 1,449 |
Restricted investments | 261 | 261 |
Deferred income taxes, net | 228 | 227 |
Other assets | 134 | 143 |
Total assets | 15,513 | 14,892 |
Current liabilities: | ||
Medical claims and benefits payable | 4,571 | 4,204 |
Amounts due government agencies | 2,501 | 2,294 |
Accounts payable, accrued liabilities and other | 1,114 | 1,252 |
Deferred revenue | 328 | 418 |
Total current liabilities | 8,514 | 8,168 |
Long-term debt | 2,180 | 2,180 |
Finance lease liabilities | 202 | 205 |
Other long-term liabilities | 124 | 124 |
Total liabilities | 11,020 | 10,677 |
Stockholders’ equity: | ||
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at March 31, 2024 and $58 million at December 31, 2023 | 0 | 0 |
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding | 0 | 0 |
Additional paid-in capital | 390 | 410 |
Accumulated other comprehensive loss | (85) | (82) |
Retained earnings | 4,188 | 3,887 |
Total stockholders’ equity | 4,493 | 4,215 |
Total liabilities and stockholders’ equity | $ 15,513 | $ 14,892 |